Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Mitomycin | Mitomycin 20 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-390 | 68001-0390-77 | — |
| Mitomycin | Mitomycin 40 mg/80mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-391 | 68001-0391-79 | — |
| Daptomycin | Daptomycin 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-376 | 68001-0376-68 | — |
| Ursodiol | Ursodiol 250 mg/1 | TabletOral | 68001-377 | 68001-0377-00 | — |
| Ursodiol | Ursodiol 500 mg/1 | TabletOral | 68001-378 | 68001-0378-00 | — |
| Isosorbideisosorbide dinitrate | Isosorbide dinitrate 5 mg/1 | TabletOral | 68001-373 | 68001-0373-00 | — |
| Isosorbideisosorbide dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | 68001-374 | 68001-0374-00 | — |
| Isosorbideisosorbide dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | 68001-375 | 68001-0375-00 | — |
| Sildenafil | Sildenafil citrate 20 mg/1 | Tablet, Film coatedOral | 68001-363 | 68001-0363-05 | — |
| Cefdinir | Cefdinir 300 mg/1 | CapsuleOral | 68001-362 | 68001-0362-06 | — |
| Metronidazole | Metronidazole 250 mg/1 | Tablet, Film coatedOral | 68001-364 | 68001-0364-00 | — |
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | 68001-365 | 68001-0365-0068001-0365-03 | — |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | 68001-356 | 68001-0356-0068001-0356-03 | — |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 68001-358 | 68001-0358-0068001-0358-03 | — |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 68001-360 | 68001-0360-0068001-0360-03 | — |
| Montelukast | Montelukast sodium 10 mg/1 | TabletOral | 68001-361 | 68001-0361-0368001-0361-0468001-0361-05 | — |
| Palonosetron | Palonosetron hydrochloride .05 mg/mL | Injection, SolutionIntravenous | 68001-355 | 68001-0355-25 | — |
| Gemcitabine | Gemcitabine hydrochloride 100 mg/mL | Injection, SolutionIntravenous | 68001-342 | 68001-0342-34 | — |
| Gemcitabine | Gemcitabine hydrochloride 100 mg/mL | Injection, SolutionIntravenous | 68001-348 | 68001-0348-36 | — |
| Gemcitabine | Gemcitabine hydrochloride 100 mg/mL | Injection, SolutionIntravenous | 68001-359 | 68001-0359-37 | — |
| Duloxetine Delayed-Releaseduloxetine hydrochloride | Duloxetine hydrochloride 40 mg/1 | Capsule, Delayed release pelletsOral | 68001-368 | 68001-0368-04 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 68001-345 | 68001-0345-2668001-0345-36 | — |
| Lisinopril | Lisinopril 2.5 mg/1 | TabletOral | 68001-332 | 68001-0332-0068001-0332-03 | — |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | 68001-333 | 68001-0333-0068001-0333-08 | — |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | 68001-334 | 68001-0334-0068001-0334-08 | — |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | 68001-335 | 68001-0335-0068001-0335-08 | — |
| Lisinopril | Lisinopril 30 mg/1 | TabletOral | 68001-336 | 68001-0336-00 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-313 | 68001-0313-56 | — |
| Meropenem | Meropenem 500 mg/20mL | Injection, Powder, For solutionIntravenous | 68001-323 | — | — |
| Meropenem | Meropenem 1 g/30mL | Injection, Powder, For solutionIntravenous | 68001-324 | — | — |
| Triamterene and Hydrochlorothiazide | Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | 68001-327 | 68001-0327-0068001-0327-03 | — |
| Triamterene and Hydrochlorothiazide | Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1 | TabletOral | 68001-328 | 68001-0328-0068001-0328-03 | — |
| Cisplatin | Cisplatin 1 mg/mL | InjectionIntravenous | 68001-283 | 68001-0283-2768001-0283-32 | — |
| Nadolol | Nadolol 20 mg/1 | TabletOral | 68001-317 | 68001-0317-00 | — |
| Nadolol | Nadolol 40 mg/1 | TabletOral | 68001-318 | 68001-0318-00 | — |
| Nadolol | Nadolol 80 mg/1 | TabletOral | 68001-319 | 68001-0319-00 | — |
| Diclofenac Sodium | Diclofenac sodium 25 mg/1 | Tablet, Delayed releaseOral | 68001-279 | 68001-0279-00 | — |
| Diclofenac Sodium | Diclofenac sodium 50 mg/1 | Tablet, Delayed releaseOral | 68001-280 | 68001-0280-0068001-0280-0668001-0280-08 | — |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | 68001-281 | 68001-0281-0068001-0281-0368001-0281-06+1 more | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 10 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 68001-130 | 68001-0130-00 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 10 mg/1; Benazepril hydrochloride 40 mg/1 | CapsuleOral | 68001-131 | 68001-0131-00 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 2.5 mg/1; Benazepril hydrochloride 10 mg/1 | CapsuleOral | 68001-132 | 68001-0132-00 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 10 mg/1 | CapsuleOral | 68001-133 | 68001-0133-00 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 68001-134 | 68001-0134-00 | — |
| Amlodipine Besylate and Benazepril Hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 40 mg/1 | CapsuleOral | 68001-135 | 68001-0135-00 | — |
| Quinapril | Quinapril hydrochloride 40 mg/1 | TabletOral | 68001-260 | 68001-0260-05 | — |
| Carvedilol | Carvedilol 12.5 mg/1 | Tablet, Film coatedOral | 68001-151 | 68001-0151-0068001-0151-03 | — |
| Carvedilol | Carvedilol 25 mg/1 | Tablet, Film coatedOral | 68001-152 | 68001-0152-0068001-0152-03 | — |
| Carvedilol | Carvedilol 3.125 mg/1 | Tablet, Film coatedOral | 68001-153 | 68001-0153-0068001-0153-03 | — |
| Carvedilol | Carvedilol 6.25 mg/1 | Tablet, Film coatedOral | 68001-154 | 68001-0154-0068001-0154-03 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.